职 称:研究员
导师资格:硕士生导师
最高学历:博士
毕业时间:2004.6
主研方向:
干细胞的基础研究与临床转化应用
肝癌微环境、肿瘤生物治疗
社会兼职:
医疗专长:
肝胆外科常见疾病诊治、肿瘤免疫细胞治疗
获奖情况:
获全国百篇优秀博士学位论文奖励、新世纪优秀人才支持计划
论 著:
1）ZhangQ,ChenG,LiuX,QianQ.Monoclonalantibodiesastherapeuticagentsinoncologyandantibodygenetherapy.CellRes.2007Feb;17(2):89-99.
2）LiT,YangY,HuaX,WangG,LiuW,JiaC,TaiY,ZhangQ※,ChenG.HepatocellularCarcinoma-AssociatedFibroblastsTriggerNKCellDysfunctionviaPGE2andIDO.CancerLett.2011Dec17.[Epubaheadofprint]
3）WangGY,YangY,LiH,ZhangJ,JiangN,LiMR,ZhuHB,ZhangQ※,ChenGH.AscoringmodelbasedonneutrophiltolymphocyteratiopredictsrecurrenceofHBV-associatedhepatocellularcarcinomaafterlivertransplantation.PLoSOne.2011;6(9):e25295.
4）ChenW,WuY,LiuW,WangG,WangX,YangY,ChenW,TaiY,LuM,QianQ,ZhangQ※,ChenG.Enhancedantitumorefficacyofanovelfiberchimericoncolyticadenovirusexpressingp53onhepatocellularcarcinoma.CancerLett.2011;307(1):93-103.
5）WangGY,YangY,LiH,ZhangJ,LiMR,ZhangQ※,ChenGH.RapamycincombinedwithdonorimmaturedendriticcellspromotesliverallograftsurvivalinassociationwithCD4(+)CD25(+)Foxp3(+)regulatoryTcellexpansion.HepatolRes.2012;42(2):192-202
6）ZHANGYing-cai,ZHANGQi※,LIHua,ZHANGJian,WANGGen-shu,XUChi,YIShu-hong,YIHui-min,CAIChang-jie,LUMin-qiang,YANGYang,CHENGui-hua.Prognosticfactorsforlatemortalityafterlivertransplantationforbenignend-stageliverdisease.ChinMedJ(Engl).2011,124:4229-35.
7）LeiJ,WangZ,HuiD,YuW,ZhouD,XiaW,ChenC,ZhangQ,WangZ,ZhangQ※,XiangAP.LigationofTLR2andTLR4onmurinebonemarrow-derivedmesenchymalstemcellstriggersdifferentialeffectsontheirimmunosuppressiveactivity.CellImmunol.2011;271(1):147-56.CellImmunol.2011;271(1):147-56
8）ZHANGQi,YANGYang,ZHANGJian,WANGGuo-ying,LIUWei,QIUDong-bo,HEIZi-qing,YINGQi-long,CHENGui-hua.Efficientderivationoffunctionalhepatocytesfrommouseinducedpluripotentstemcellsbyacombinationofcytokinesandsodiumbutyrate.ChinMedJ(Engl).2011,124:3786-93.
9）ZhangQ,NieM,ShamJ,SuC,XueH,ChuaD,WangW,CuiZ,LiuY,LiuC,JiangM,FangG,LiuX,WuM,QianQ.Effectivegene-viraltherapyfortelomerase-positivecancersbyselectivereplicative-competentadenoviruscombingwithendostatingene.CancerRes.2004,64(15):5390-7.
10）ZhangQ,ChenG,WangX,PengL,LiuC,YangY,SuC,WuH,LiL,LiuX,WuM&QianQ.IncreasedSafetywithPreservedAntitumoralEfficacyonHepatocellularCarcinomawithDual-regulatedOncolyticAdenovirus.ClinicalCancerResearch2006;12(21),6523-6531.
11）JiangM,ShiW,ZhangQ(cofirstauthor),WangX,GuoM,CuiZ,SuCh,YangQ,LiY,ShamJ,LiuX,WuM,andQianQ.GeneTherapyforHer2over-expressioncancersusingadenovirusmediatedfull-lengthanti-Her2antibody.ClinicalCancerResearch2006;12(20):6179-85
专 著:
E-mailZhangq27@mail.sysu.edu.cn
